Intuitive Surgical designs and commercializes robotic-assisted surgical and diagnostic platforms, primarily the da Vinci surgical systems that enable minimally invasive procedures across general, urologic, gynecologic, cardiothoracic, and head and neck specialties, as well as the Ion endoluminal system for lung biopsies. The company sells systems and instruments to hospitals, integrated delivery networks, and surgery centers globally, generating revenue from capital equipment sales, recurring consumables and instruments, and service and subscription offerings including maintenance, digital analytics platforms, and surgical simulation tools. Intuitive competes against open surgery, conventional laparoscopy, and emerging robotic competitors, differentiating itself through clinical innovation, product quality, surgeon education, and demonstrated procedural value.